Molekulare Diagnostik - Nukleinsäure Detektion
Nachweis der klinischen Parameter
Nachfolgend eine aktuelle Übersicht über die verfügbaren Kits unserer Partner:
Sacace (S), GeneProof (G), AnatoliaGeneworks (A), InterLabService (I) und DiagCor (D)
| Kataloge: | ||||
| - Sacace | - GeneProof | - AnatoliaGeneworks | - InterLabService | - DiagCor |
| Klinische Parameter |
Einzel-Nachweis |
Multiplex Nachweis |
qPCR |
Endpunkt PCR |
Fluoreszenz EP PCR |
PCR/Hybrid |
CE/IVD |
Partner |
|
| Hepatitis Viruses |
|||||||||
| Hepatitis A (HAV) |
● | ● | ● | ● | S, I |
||||
| Hepatitis B (HBV) | ● | ● | ● | ● | ● | S, A, I |
|||
| Hepatitis C (HCV) | ● | ● | ● | ● | S, A, I |
||||
| Hepatitis C Virus Genotyping | ● | ● | ● | ● | S, A, I |
||||
| Hepatitis D (HDV) | ● | ● | ● | ● | ● | S, A, I |
|||
| Hepatitis G (HGV) | ● | ● | ● | ● | S, I |
||||
| HCV/HBV/HIV | ● | ● | ● | ● | S |
||||
| Human Immunodeficiency Virus |
|||||||||
| HIV-1 |
● | ● |
● |
● |
S, A |
||||
| HIV DNA |
● |
S |
|||||||
| HIV associated infections HLA B5701 |
● |
● | ● |
● |
S |
||||
| HIV asscociated infections Pneumocystis carinii |
● |
● |
● |
● |
S |
||||
| Human Papilloma Virus |
|
||||||||
| Screening of high carcinogenic risk HPV genotypes | ● | ● | ● |
● |
● |
● |
S, D, I |
||
| Typing of high carcinogenic risk HPV genotypes |
● | ● | ● | ● | ● |
● |
S, D, I |
||
| Low carcinogenic risk HPV genotypes | ● | ● | ● |
● |
● |
● |
S, D, I |
||
| Sexually transmitted diseases | |
||||||||
| Chlamydia trachomatis | ● |
● |
● |
● |
● |
● |
S, A, G, I |
||
| Neisseria gonorrhoeae | ● |
● |
● |
● | ● | S, G, I |
|||
| Trichomonas vaginalis | ● |
● | ● |
● |
S, I |
||||
| Multiplex PCR Kits | ● |
● |
● |
S, I |
|||||
| Candida albicans | ● |
● |
● |
● |
● |
S, I |
|||
| Treponema pallidum | ● |
● |
● |
● |
S, I |
||||
| Bakterielle Vaginosis |
● |
● |
● |
● |
● |
S, I | |||
| Ureaplasma | ● |
● |
● |
● |
● |
S, A, I |
|||
| Mycoplasma genitalium |
● |
● |
● |
● |
● |
S, I |
|||
| Mycoplasma hominis | ● | ● |
● |
● |
● |
S, I |
|||
| Herpes Virus Infections | |||||||||
| Cytomegalovirus (CMV) | ● |
● |
● |
● |
● |
S, A, I |
|||
| Herpes Simplex, HSV 1-2 |
● | ● |
● |
● | ● | S, A, G, I |
|||
| Epstein-Barr Virus (EBV) | ● |
● |
● |
● |
S, A, I |
||||
| Human herpesvirus 6 (HHV-6) | ● |
● |
● |
● |
S, A, I |
||||
| Varicella Zoster Virus |
● |
● |
● |
● |
● |
S, I |
|||
| G |
|||||||||
| Respiratory Infections | |||||||||
| Influenza A, B |
● |
● |
● |
● |
I |
||||
| Chlamydia & Mycoplasma pneumoniae | ● |
● |
● |
● |
● |
S, G, I |
|||
| Pseudomonas aeruginosa | ● |
● | ● |
● |
● |
S |
|||
| Legionella pneumophila | ● |
● |
● |
● |
G, I |
||||
| Human respiratory syncytial virus (hRSV) | ● |
● |
● |
● |
● |
S |
|||
| Acute Respiratory Viral Infections | ● |
● |
● |
● |
S |
||||
| Bordetella Pertussis | ● |
● |
● |
● |
● |
S |
|||
| BirdFlu Avian Influenza, H5N1 | ● |
● |
● |
● |
● |
I |
|||
| Adenovirus | ● |
● |
|
● |
● |
● |
I |
||
| Onkological Diseases | |||||||||
| chronic myelogenous leukaemia (CML) |
● |
● |
● | ● |
S, I |
||||
| KRAS (7 Sequenzen von Codon 12 und 13) | |||||||||
| TORCH infections | |||||||||
| Rubella | ● |
● |
● |
● |
● |
S, I |
|||
| Toxoplasmose | ● | ● |
● |
● |
● |
S, I |
|||
| Parovirus B19 (B19V) | ● |
● |
● |
● |
● |
S, A, I |
|||
| |
|||||||||
| Tuberculosis | |
||||||||
| Tuberculosis drug resistance | ● |
● |
● |
● |
● |
S, D |
|||
| MTB | ● | ● |
● |
● |
● |
● |
S, G, D, I |
||
| MTBC | ● |
● |
● |
● |
● |
A, D |
|||
| Neurological Infections | |||||||||
| Enteroviruses | ● |
● |
● |
● |
● |
● |
● |
S, I |
|
| Meningitis | ● |
● |
● |
● |
S, I |
||||
| JK Virus |
● |
● |
● |
● |
A |
||||
| BKV Virus | ● |
● |
● |
● |
A |
||||
| H. Influenza | ● |
● |
● |
● |
I |
||||
| St.pneumoniae | ● |
● |
● |
● |
I |
||||
| Intestinal infections | |||||||||
| Acute Intestinal Infections (A.I.I.) | ● |
● |
● |
● |
● |
S, I |
|||
| Rotavirus/Norovirus/Astrovirus | ● |
● |
● |
● |
● |
S, I |
|||
| Shigella/Salmonella/Campilobacter | ● |
● |
● |
● |
● |
S, I |
|||
| Food Pathogenes, EHEC, Corona |
● |
● |
● |
● |
S, I |
||||
| Helicobacter Pylori | ● |
● |
● |
● | S |
||||
| Dangerous infections | |||||||||
| Lyme disease | ● |
● |
● |
● |
S, G, I |
||||
| Brucellosis | ● |
● | ● |
● | S, A, I |
||||
| Leptospirosis | ● |
● |
● |
● |
S, I |
||||
| Tick-Born disease | ● |
S, I |
|||||||
| West Nile Virus | ● | ● |
● |
● |
S, A, I |
||||
| Orthopoxovirus | ● |
S |
|||||||
| Coxiella burneeti | ● |
S |
|||||||
| Single Nucleotide Polymorphism SNP | |||||||||
| Cardiovasculaire diseases CVD | ● |
● |
● |
● |
S, A | ||||
| Factor II | ● |
● |
● |
● |
G |
||||
| Factor V Leiden | ● |
● | ● |
● |
A, G |
||||
| MTHFR C677T | ● |
● |
● |
● |
A, G |
||||
| MTHFRA1298C | ● |
● | ● |
● |
G |
||||
| Prothrombin | ● |
● |
● |
● |
A |
||||
| JAK2 | ● |
● |
● |
● |
A |
||||
| Pyogene Infektionen und MRSA | |||||||||
| MRSA | ● |
● |
● |
● |
S |
||||
| Streptococcus agalactiae | ● |
● |
● |
● |
S |
||||
| Streptococcus pyogenes | ● |
● |
● |
● |
S |
||||
| Pseudomonas aeruginosa | ● |
● |
● |
● | S |
||||
| Genetically modified organisms (GMO) | |||||||||
| GMO | ● | ● |
● |
S |
|||||
| Food allergens | |||||||||
| Food allergens |
● |
● | ● |
S |
|||||
| Veterinarian parameters | |||||||||
| Veterinarian parameters |
● | ● | ● | S | |||||
Produktauskünfte (Verfügbarkeit, Preisabfrage, Bestellungen)
Anfragen senden Sie bitte an info@genxpress.at
